Industry News

Dexcom Thanks Providers During National Diabetes Awareness Month.

You are here

Thursday, November 8, 2018

National Diabetes Awareness Month 2018

November is National Diabetes Awareness Month, a time when communities across the country bring attention to the impact and treatment of diabetes.

The Critical Role of Providers in Diabetes Treatment

During National Diabetes Awareness Month, Dexcom would like to show our appreciation for the vital role that providers play in diabetes treatment, education, training and access to care for millions of Americans. To support their role, Dexcom remains committed to empowering providers with the best technology and resources for diabetes management, including continuous glucose monitoring (CGM). CGM helps providers and patients proactively manage diabetes, and it is the only diabetes management tool proven to reduce A1C while decreasing time spent in hypoglycemia.1,2


Clinic Resources

Dexcom offers providers valuable Education and Research Resources to enhance their practice, support treatment decisions, and educate patients, including Videos and Clinical Evidence. Here are a few tools we offer:


Diabetes Care

Dexcom encourages providers to talk to their patients about potential opportunities to leverage deductibles and end-of-year covered benefits.

If you are a clinician and want to learn more about how Dexcom’s continuous glucose monitoring systems can help your practice, please contact us. You may also like to visit our Forms page to find resources to help your patients get started on Dexcom CGM. We appreciate all you do to help improve the lives of millions of people living with diabetes!


The Impact of Diabetes on Americans

More than 100 million U.S. adults are living with diabetes or prediabetes, according to a report released by the Centers for Disease Control and Prevention (CDC) last year.3 At a cost of $327 billion, diabetes has become the most expensive chronic disease in the U.S., according to the American Diabetes Association’s (ADA) recently released “Economic Costs of Diabetes in the U.S. in 2017,” a report published online in Diabetes Care.4 For those who've been diagnosed, diabetes impacts nearly every decision they make daily, and requires 24/7 management. Dexcom remains committed to helping providers help people living with diabetes through best-in-class technology and support services that improve patient outcomes.


*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
1Beck RW, Riddlesworth T, Ruedy K, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial. JAMA. 2017;317(4):371–378. doi:10.1001/jama.2016.19975. 
2Lind M, Polonsky W, Hirsch IB, et al. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomised Clinical Trial. JAMA. 2017;317(4):379-387.

Contact Dexcom

If you are a clinician and want to learn more about Dexcom’s Continuous Glucose Monitoring Systems, please fill out the form and a Dexcom representative will contact you.

If you are a Dexcom User or Patient, please contact Dexcom here.

The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.